In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.

David S Pisetsky

Annals of internal medicine（2024）

引用 0|浏览3
暂无评分
摘要
SOURCE CITATION:Rech J, Tascilar K, Hagen M, et al. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet. 2024;403:850-859. 38364841.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要